AU5182099A - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation

Info

Publication number
AU5182099A
AU5182099A AU51820/99A AU5182099A AU5182099A AU 5182099 A AU5182099 A AU 5182099A AU 51820/99 A AU51820/99 A AU 51820/99A AU 5182099 A AU5182099 A AU 5182099A AU 5182099 A AU5182099 A AU 5182099A
Authority
AU
Australia
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU51820/99A
Inventor
Nicola Kim Rylance
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quadrant Healthcare UK Ltd
Original Assignee
Quadrant Healthcare UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadrant Healthcare UK Ltd filed Critical Quadrant Healthcare UK Ltd
Publication of AU5182099A publication Critical patent/AU5182099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
AU51820/99A 1998-08-11 1999-08-02 Pharmaceutical formulation Abandoned AU5182099A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9817470.9A GB9817470D0 (en) 1998-08-11 1998-08-11 Pharmaceutical formulation
GB9817470 1998-08-11
PCT/GB1999/002527 WO2000009084A2 (en) 1998-08-11 1999-08-02 Biodegradable microparticles gel composition

Publications (1)

Publication Number Publication Date
AU5182099A true AU5182099A (en) 2000-03-06

Family

ID=10837065

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51820/99A Abandoned AU5182099A (en) 1998-08-11 1999-08-02 Pharmaceutical formulation

Country Status (6)

Country Link
EP (1) EP1105095A2 (en)
JP (1) JP2002522467A (en)
AU (1) AU5182099A (en)
CA (1) CA2340177A1 (en)
GB (1) GB9817470D0 (en)
WO (1) WO2000009084A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632457B1 (en) * 1998-08-14 2003-10-14 Incept Llc Composite hydrogel drug delivery systems
EP1446104B2 (en) 2001-11-01 2011-08-03 Novartis AG Spray drying methods
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
BR102012011209A2 (en) * 2012-05-11 2014-03-25 Bioactive Biomateriais Ltda BIODEGRADABLE THREE-DIMENSIONAL MATERIAL AND BIODEGRADABLE THREE-DIMENSIONAL MATERIAL PREPARATION PROCESS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9107628D0 (en) * 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
IT1255076B (en) * 1992-04-01 1995-10-18 Inverni Della Beffa Spa BIODEGRADABLE MICROSPHERES FOR PHARMACEUTICAL AND COSMETIC USE
WO1993025221A1 (en) * 1992-06-11 1993-12-23 Alkermes Controlled Therapeutics, Inc. Erythropoietin drug delivery system

Also Published As

Publication number Publication date
GB9817470D0 (en) 1998-10-07
EP1105095A2 (en) 2001-06-13
JP2002522467A (en) 2002-07-23
CA2340177A1 (en) 2000-02-24
WO2000009084A3 (en) 2000-06-02
WO2000009084A2 (en) 2000-02-24

Similar Documents

Publication Publication Date Title
AU1225000A (en) Combined pharmaceutical estrogen-androgen-progestin
HK1041224A1 (en) New pharmaceutical formulation
AU6740298A (en) Pharmaceutical composition
AU4413299A (en) Stabilized pharmaceutical compositions
AU4328800A (en) Pharmaceutical formulation
AU8107998A (en) Pharmaceutical compositions
AU1409100A (en) Drugs
AU6715600A (en) Pharmaceutical formulations
AU9343098A (en) Pharmaceutical composition
AU4977300A (en) Pharmaceutical formulations
AU1385801A (en) Pharmaceutical formulations
GB9818927D0 (en) Pharmaceutical formulation
AUPP332898A0 (en) Pharmaceutical composition
AU6480299A (en) Pharmaceutical compounds
AU1688099A (en) Pharmaceutical preparation
AU5378599A (en) Oral formulation
AU3839900A (en) Pharmaceutical formulation
AU5182099A (en) Pharmaceutical formulation
GB9822333D0 (en) Pharmaceutical formulation
AU1388501A (en) Pharmaceutical formulation
AU5184599A (en) Pharmaceutical compounds
AU2279800A (en) Pharmaceutical preparation
AU1649700A (en) Novel formulation
AU3989100A (en) Pharmaceutical gel formulation
ZA994697B (en) Pharmaceutical formulation.

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase